A case-control study to assess the risk of immune thrombocytopenia associated with vaccines

Blood

Volumn 120, Issue 25, 2012, Pages 4938-4944

  Grimaldi Bensouda, Lamiae ^a,b   Michel, Marc ^c   Aubrun, Elodie ^a   Leighton, Pamela ^d   Viallard, Jean Francois ^e   Adoue, Daniel ^f   Magy Bertrand, Nadine ^g   Tisserand, Guillaume ^g   Khellaf, Mehdi ^c   Durand, Jean Marc ^h   Quittet, Philippe ⁱ   Fain, Olivier ^j   Bonnotte, Bernard ^k   Morin, Anne Sophie ^j   Limal, Nicolas ^c   Costedoat Chalumeau, Nathalie ^l   Morel, Nathalie ^l   Pan Petesch, Brigitte ^m   Decaux, Olivier ⁿ   Mahevas, Matthieu ^c   Ruel, Michel ^o   Sacre, Karim ^p   Lefrere, Francois ^q   Abenhaim, Lucien ^d,r   Godeau, Bertrand ^c   more..

^a LA SER   (France)

^b Bioinformatique et Chimie Moléculaire   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d London School of Hygiene Tropical Medicine   (United Kingdom)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f CHU PURPAN   (France)

^g UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^h HÔPITAL DE LA CONCEPTION   (France)

ⁱ HÔPITAL SAINT ELOI   (France)

^j HÔPITAL JEAN VERDIER   (France)

^k HÔPITAL DU BOCAGE   (France)

^l PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^m BREST UNIVERSITY HOSPITAL   (France)

ⁿ RENNES UNIVERSITY HOSPITAL   (France)

^o Hopital Max Fourestier   (France)

^p BICHAT HOSPITAL   (France)

^q HÔPITAL NECKER ENFANTS MALADES   (France)

^r LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; IMMUNOGLOBULIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE THROMBOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIA; VACCINATION;

EID: 84871025847     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-05-431098     Document Type: Article

References (37)

1. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16): 4190-4207.
2. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996; 88(1):3-40. (Pubitemid 26230668)
3. Fogarty PF, Segal JB. The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol. 2007;14(5):515-519. (Pubitemid 47457643)
4. Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood. 1999;94(3):909-913. (Pubitemid 29361821)
5. Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol. 2010;85(3):174-180.
6. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113(26):6511-6521.
7. Chen RT, Pless R, Destefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun. 2001;16(3):309-318. (Pubitemid 32566120)
8. Toplak N, Avcin T. Influenza and autoimmunity. Ann N Y Acad Sci. 2009;1173:619-626.
9. Miller E, Waight P, Farrington CP, Andrews N, Stowe J, Taylor B. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child. 2001; 84(3):227-229. (Pubitemid 32250829)
10. Black C, Kaye JA, Jick H. MMR vaccine and idiopathic thrombocytopaenic purpura. Br J Clin Pharmacol. 2003;55(1):107-111. (Pubitemid 36110846)
11. Mantadakis E, Farmaki E, Buchanan GR. Thrombocytopenic purpura after measles-mumpsrubella vaccination: a systematic review of the literature and guidance for management. J Pediatr. 2010;156(4):623-628.
12. O'Leary ST, Glanz JM, McClure DL, et al. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents. Pediatrics. 2012;129(2):248-255.
13. Bertuola F, Morando C, Menniti-Ippolito F, et al. Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy. Drug Saf. 2010;33(1): 65-72.
14. Jadavji T, Scheifele D, Halperin S; Canadian Paediatric Society/Health Cananda Immunization Monitoring Program. Thrombocytopenia after immunization of Canadian children, 1992 to 2001. Pediatr Infect Dis J. 2003;22(2):119-122.
15. Moussalem M, Yassine N. Immune thrombocytopenic purpura in childhood: a Lebanese perspective. Mol Immunol. 2003;39(17-18):1105-1107. (Pubitemid 36776564)
16. Tishler M, Levy O, Amit-Vazina M. Immune thrombocytopenic purpura following influenza vaccination. Isr Med Assoc J. 2006;8(5):322-323. (Pubitemid 43805047)
17. Mantadakis E, Farmaki E, Thomaidis S, Tsalkidis A, Chatzimichael A. A case of immune thrombocytopenic purpura after influenza vaccination: consequence or coincidence? J Pediatr Hematol Oncol. 2010;32(6):e227-e229.
18. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11): 2386-2393.
19. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
20. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4: 295-306.
21. Abenhaim L, Moride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. New Engl J Med. 1996;335(9):609-616. (Pubitemid 26277950)
22. Grimaldi-Bensouda L, Rossignol M, Aubrun E, El Kerri N, Benichou J, Abenhaim L; the PGRx Study Group. Agreement between patients' self-report and physicians' prescriptions on cardiovascular drug exposure: the PGRx database experience. Pharmacoepidemiol Drug Saf. 2010;19(6): 591-595.
23. Grimaldi-Bensouda L, Rossignol M, Aubrun E, Benichou J, Abenhaim L; the PGRx Study Group. Agreement between patients' self-report and physicians' prescriptions on nonsteroidal antiinflammatory drugs and other drugs used in musculoskeletal disorders: the international Pharmacoepidemiologic General Research eXtension database. Pharmacoepidemiol Drug Saf. 2012;21(7):753-759.
24. Rischewski JR, Imbach P, Paulussen M, Kühne T. Idiopathic thrombocytopenic purpura (ITP): is there a genetic predisposition? Pediatr Blood Cancer. 2006;47(5 Suppl):678-680. (Pubitemid 44360026)
25. Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis and management. J Thromb Haemost. 2009;7(6):911-918.
26. Direction de la Recherche, des Études, de l'Évaluation et des Statistiques (Drees). Les consultations et visites des médecins généralistes: Un essai de typologie. Numero 315, Juin 2004. Available from: http://onala.free.fr/drees315.pdf. Accessed August 3, 2012
27. Randl ML, Wright JF. Virus-associated idiopathic thrombocytopenic purpura. Transfus Sci. 1998; 19:253-259. (Pubitemid 29005169)
28. Kaneko H, Ohkawara Y, Nomura K, Horiike S, Taniwaki M. Relapse of idiopathic thrombocytopenic purpura caused by influenza A virus infection: a case report. J Infect Chemother. 2004; 10(6):364-366. (Pubitemid 40142829)
29. Huang WT, Huang WI, Huang YW, Hsu CW, Chuang JH. The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis. Vaccine. 2012;30(12):2168-2172.
30. Garbe E, Andersohn F, Bronder E, et al. Drug-induced immune thrombocytopenia: results from the Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol. 2012;68(5):821-832.
31. Sánchez Fayos J, Olavarría E, Román A, Cabello A, Soto C, Paniagua C. Idiopathic thrombocytopenic purpura in 5 members of a family [article in Spanish]. Sangre (Barc). 1994;39(3):215-217.
32. Patel AP. Idiopathic autoimmune thrombocytopenia and neutropenia in siblings. Eur J Haematol. 2002;69(2):120-121. (Pubitemid 35178114)
33. Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence? Lancet. 2003;362(9396):1659-66. (Pubitemid 37443537)
34. Battafarano DF, Battafarano NJ, Larsen L, et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum. 1998;41:1828-34. (Pubitemid 28465537)
35. Wiesik-Szewczyk E, Romanowska M, Mielnik P, et al. Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety. Clin Rheumatol. 2010;29(6):605-13.
36. Saad CG, Borba EF, Aikawa NE, et al. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases. Ann Rheum Dis. 2011;70(6):1068-1073.
37. Salemi S, D'Amelio R. Are anti-infectious vaccinations safe and effective in patients with autoimmunity? Int Rev Immunol . 2010;29(3):270-314.